Korro Bio, Inc.

General ticker "KRRO" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $167.1M (TTM average)

Korro Bio, Inc. follows the US Stock Market performance with the rate: 9.9%.

Estimated limits based on current volatility of 7.6%: low 9.74$, high 11.35$

Factors to consider:

  • Total employees count: 104 as of 2024
  • Price in estimated range
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [4.78$, 15.90$]
  • 2026-12-31 to 2027-12-31 estimated range: [3.53$, 11.93$]

Financial Metrics affecting the KRRO estimates:

  • Negative: with PPE of -0.6 at the end of fiscal year the price was high
  • Negative: Operating cash flow per share per price, % of -103.65 <= 0.02
  • Negative: negative Operating income
  • Positive: Investing cash flow per share per price, % of 58.04 > -0.63
  • Negative: negative Net income
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Positive: 42.58 < Shareholder equity ratio, % of 45.32 <= 64.15
  • Negative: Industry earnings per price (median), % of -12.76 <= 0
  • Negative: Inventory ratio change, % of 5.67 > 0.80

Similar symbols

Short-term KRRO quotes

Long-term KRRO plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $2.27MM $6.39MM
Operating Expenses $84.53MM $94.18MM $128.25MM
Operating Income $-84.53MM $-91.91MM $-121.86MM
Non-Operating Income $3.39MM $8.47MM $5.23MM
R&D Expense $57.25MM $63.64MM $65.58MM
Income(Loss) $-81.14MM $-83.44MM $-116.62MM
Taxes $0.03MM $0.14MM $0.64MM
Profit(Loss)* $-81.17MM $-83.58MM $-117.26MM
Stockholders Equity $169.91MM $160.41MM $51.44MM
Assets $221.66MM $226.24MM $113.51MM
Operating Cash Flow $-67.28MM $-60.07MM $-78.56MM
Capital expenditure $7.84MM $17.90MM $0.52MM
Investing Cash Flow $11.16MM $-123.35MM $43.99MM
Financing Cash Flow $187.76MM $69.36MM $0.69MM
Earnings Per Share** $-53.09 $-9.37 $-12.48

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.